Gu Q - Search Results

1

VKORC1-1639G>A, CYP2C9, EPHX1691A>G genotype, body weight, and age are important predictors for warfarin maintenance doses in patients with mechanical heart valve prostheses in southwest China.

Gu Q, Kong Y, Schneede J, Xiao YB, Chen L, Zhong QJ, Wang XF, Hao J, Chen BC, Chen JJ. Gu Q, et al. Eur J Clin Pharmacol. 2010 Dec;66(12):1217-27. doi: 10.1007/s00228-010-0863-9. Epub 2010 Sep 15. Eur J Clin Pharmacol. 2010. PMID: 20842355

2

Hypoxia-induced SOCS3 is limiting STAT3 phosphorylation and NF-κB activation in congenital heart disease.

Gu Q, Kong Y, Yu ZB, Bai L, Xiao YB. Gu Q, et al. Biochimie. 2011 May;93(5):909-20. doi: 10.1016/j.biochi.2011.02.009. Epub 2011 Feb 24. Biochimie. 2011. PMID: 21354254

3

Identification of differently expressed genes and small molecule drugs for Tetralogy of Fallot by bioinformatics strategy.

Gu Q, Chen XT, Xiao YB, Chen L, Wang XF, Fang J, Chen BC, Hao J. Gu Q, et al. Pediatr Cardiol. 2014 Jun;35(5):863-9. doi: 10.1007/s00246-014-0868-8. Epub 2014 Jan 25. Pediatr Cardiol. 2014. PMID: 24463614

4

Silencing suppressor of cytokine signaling 3 induces apoptosis and activates the p-STAT3/NF-κB pathway in hypoxic cultivated H9c2 cells.

Gu Q, Xiao YB, Wang Y. Gu Q, et al. J Physiol Biochem. 2024 Feb;80(1):127-136. doi: 10.1007/s13105-023-00989-7. Epub 2023 Oct 19. J Physiol Biochem. 2024. PMID: 37856074

5

FXR activation reduces the formation of macrophage foam cells and atherosclerotic plaque, possibly by down regulating hepatic lipase in macrophages.

Gu Q, Liu J, Shen LL. Gu Q, et al. FEBS Open Bio. 2024 Nov 27. doi: 10.1002/2211-5463.13925. Online ahead of print. FEBS Open Bio. 2024. PMID: 39601316 Free article.

6

Construction of feature selection and efficacy prediction model for transformation therapy of locally advanced pancreatic cancer based on CT, ¹⁸F-FDG PET/CT, DNA mutation, and CA199.

Qi L, Li X, Ni J, Du Y, Gu Q, Liu B, He J, Du J. Qi L, et al. Among authors: gu q. Cancer Cell Int. 2025 Jan 19;25(1):19. doi: 10.1186/s12935-025-03639-8. Cancer Cell Int. 2025. PMID: 39828699

7

Safety, efficacy, and immunogenicity of a novel IgG degrading enzyme (KJ103): results from two randomised, blinded, phase 1 clinical trials.

Cao M, Katial R, Liu Y, Lu X, Gu Q, Chen C, Liu K, Zhu Z, Marshall MR, Yu Y, Wang Z. Cao M, et al. Among authors: gu q. Gene Ther. 2025 Jan 18. doi: 10.1038/s41434-025-00512-1. Online ahead of print. Gene Ther. 2025. PMID: 39825100

8

Microfluidic Approach for Enhanced Paeoniflorin Transdermal Delivery: A Comparative Study on Different Chips and Mixing Dynamics.

Gu Q, Xiao W, Zhu Y, Zhong W, Sui X, Liu Y, Zhang J, Wu H, Zhou R. Gu Q, et al. AAPS PharmSciTech. 2025 Jan 16;26(1):39. doi: 10.1208/s12249-024-03033-z. AAPS PharmSciTech. 2025. PMID: 39821760

9

Duodenum and ascending colonal perforation due to biliary stent migration.

Gu Q, Liu X, Zhu C, Huang J. Gu Q, et al. Heliyon. 2024 Dec 20;11(1):e41300. doi: 10.1016/j.heliyon.2024.e41300. eCollection 2025 Jan 15. Heliyon. 2024. PMID: 39811312 Free PMC article.

10

A subtype specific probe for targeted magnetic resonance imaging of M2 tumor-associated macrophages in brain tumors.

Li Y, Thamizhchelvan AM, Ma H, Padelford J, Zhang Z, Wu T, Gu Q, Wang Z, Mao H. Li Y, et al. Among authors: gu q. Acta Biomater. 2025 Jan 11:S1742-7061(25)00003-0. doi: 10.1016/j.actbio.2025.01.003. Online ahead of print. Acta Biomater. 2025. PMID: 39805525 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,749 results

Search Page

Filters